HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of thiazide-sensitive co-transport by angiotensin II in the cyp1a1-Ren2 hypertensive rat.

Abstract
Transgenic rats with inducible expression of the mouse Ren2 gene were used to elucidate mechanisms leading to the development of hypertension and renal injury. Ren2 transgene activation was induced by administration of a naturally occurring aryl hydrocarbon, indole-3-carbinol (100 mg/kg/day by gastric gavage). Blood pressure and renal parameters were recorded in both conscious and anesthetized (butabarbital sodium; 120 mg/kg IP) rats at selected time-points during the development of hypertension. Hypertension was evident by the second day of treatment, being preceded by reduced renal sodium excretion due to activation of the thiazide-sensitive sodium-chloride co-transporter. Renal injury was evident after the first day of transgene induction, being initially limited to the pre-glomerular vasculature. Mircoalbuminuria and tubuloinsterstitial injury developed once hypertension was established. Chronic treatment with either hydrochlorothiazide or an AT1 receptor antagonist normalized sodium reabsorption, significantly blunted hypertension and prevented renal injury. Urinary aldosterone excretion was increased ≈ 20 fold, but chronic mineralocorticoid receptor antagonism with spironolactone neither restored natriuretic capacity nor prevented hypertension. Spironolactone nevertheless ameliorated vascular damage and prevented albuminuria. This study finds activation of sodium-chloride co-transport to be a key mechanism in angiotensin II-dependent hypertension. Furthermore, renal vascular injury in this setting reflects both barotrauma and pressure-independent pathways associated with direct detrimental effects of angiotensin II and aldosterone.
AuthorsAli Ashek, Robert I Menzies, Linda J Mullins, Christopher O C Bellamy, Anthony J Harmar, Christopher J Kenyon, Peter W Flatman, John J Mullins, Matthew A Bailey
JournalPloS one (PLoS One) Vol. 7 Issue 4 Pg. e36311 ( 2012) ISSN: 1932-6203 [Electronic] United States
PMID22558431 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antihypertensive Agents
  • Ren2 protein, rat
  • Sodium Chloride Symporters
  • Hydrochlorothiazide
  • Angiotensin II
  • Spironolactone
  • Cytochrome P-450 CYP1A1
  • Renin
  • Losartan
Topics
  • Angiotensin II (metabolism)
  • Animals
  • Antihypertensive Agents (pharmacology)
  • Blood Pressure (drug effects)
  • Cytochrome P-450 CYP1A1 (genetics)
  • Hydrochlorothiazide (pharmacology)
  • Hypertension (metabolism, physiopathology)
  • Kidney Tubules, Distal (blood supply, drug effects, metabolism)
  • Losartan (pharmacology)
  • Male
  • Microvessels (drug effects, injuries, metabolism)
  • Natriuresis (drug effects)
  • Rats
  • Rats, Transgenic
  • Renin (genetics)
  • Sodium Chloride Symporters (metabolism)
  • Spironolactone (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: